万维提示：
1、投稿方式：邮箱投稿。
2、期刊网址：
https://cimonline.ca/index.php/cim/index
3、官网邮箱：Robert.Bortolussi@dal.ca
4、期刊刊期：季刊，一年出版4期。
2022年1月17日星期一
投稿须知【官网信息】
Authors
Submission Guidelines
Clinical and Investigative Medicine (CIM) publishes original work in the field of Clinical Investigation. Original work includes clinical or laboratory investigations and clinical reports. Reviews include information for Continuing Medical Education (CME), narrative review articles, systematic reviews, and meta-analyses.
Manuscripts, including tables, figures and a covering letter should be submitted by email directly to the Editor in Chief Dr. Robert Bortolussi at Robert.Bortolussi@dal.ca. Do not send zipped files. We will request higher quality files should your submission be accepted.
Manuscript Fees for Authors (Page Charges)
Corresponding Author
Four Pages or Less
Additional Pages
Non Canadian $1500 USD $150 USD
Canadian1 $1500 CAD $150 CAD
CSCI and CITAC Members2 $1000 CAD $100 CAD
1First, corresponding or senior author affiliated to a Canadian institution.
2This rate applies on original research articles with CSCI or CITAC/CIP members as first, corresponding or senior author. Decision on publication acceptance is based on reviewer input.
Manuscript Presentation and Submission
Manuscripts must be prepared and submitted in the manner described in the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals from the International Committee of Medical Journal Editors (2018). In addition, authors should consult the PRISMA Statement when preparing reports of systematic reviews and meta-analyses and the CONSORT Statement when preparing reports of randomized controlled trials.
Authorship and Copyright
Authors must submit a separate covering letter, signed by all authors and including their individual email addresses, stipulating that all persons listed as authors have contributed to preparing the manuscript, and that no person or persons other than the authors listed have contributed significantly in its preparation. Lead/corresponding authors are encouraged to provide an ORCID.
Authors will be asked to transfer copyright of articles accepted for publication to the Canadian Society for Clinical Investigation. The covering letter of submitted manuscripts should be accompanied by letters granting permission to reproduce previously published materials or to use illustrations that may identify subjects.
Please Note: Manuscripts describing investigations carried out on humans will not be accepted for publication unless the text states, at the beginning of the Methods section, that the study has been approved by, and carried out according to the instructions of the author's institutional Human Investigations or Ethics Committee. Reports of investigations on animals will not be accepted for publication unless the text states that the study was approved by the author's institutional Animal Investigation Committee.
Privacy and Confidentiality
Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initial, or hospital numbers should not be published in written description, photographs and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published.
Style
Manuscripts must be typed, using Microsoft Word, double spaced throughout, including tables and figure legends. Use left justification and 12 point font. Margins should be at least 2.5 cm (1 inch) around.
Each of the following sections must begin on a separate page: Title page, Abstract, Text, Acknowledgements, References, Tables, and Figure Legends. Pages should be numbered consecutively beginning with the title page.
Remember: Figures and Tables must be provided as outlined below.
……
更多详情：
https://cimonline.ca/index.php/cim/authorinfo
